275 related articles for article (PubMed ID: 33665679)
1. Exploring the role of BAFF as biomarker in the detection of uveal melanoma metastases.
Lin Z; Süsskind D
J Cancer Res Clin Oncol; 2021 May; 147(5):1389-1405. PubMed ID: 33665679
[TBL] [Abstract][Full Text] [Related]
2. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
van Essen TH; van Pelt SI; Bronkhorst IH; Versluis M; Némati F; Laurent C; Luyten GP; van Hall T; van den Elsen PJ; van der Velden PA; Decaudin D; Jager MJ
PLoS One; 2016; 11(10):e0164292. PubMed ID: 27764126
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Three-Marker Panel for the Detection of Uveal Melanoma Metastases: A Single-Center Retrospective Analysis.
Lin Z; Süsskind D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070192
[TBL] [Abstract][Full Text] [Related]
5. Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.
Bronkhorst IH; Vu TH; Jordanova ES; Luyten GP; Burg SH; Jager MJ
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5370-8. PubMed ID: 22743317
[TBL] [Abstract][Full Text] [Related]
6. Monosomy-3 Alters the Expression Profile of the Glucose Transporters GLUT1-3 in Uveal Melanoma.
Maaßen T; Vardanyan S; Brosig A; Merz H; Ranjbar M; Kakkassery V; Grisanti S; Tura A
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302435
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
8. The Correlation Between Non-Hodgkin Lymphoma and Expression Levels of B-Cell Activating Factor and Its Receptors.
Shen X; Wang M; Guo Y; Ju S
Adv Clin Exp Med; 2016; 25(5):837-844. PubMed ID: 28028945
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.
Jha J; Singh MK; Singh L; Pushker N; Bajaj MS; Sen S; Kashyap S
Int J Clin Oncol; 2019 Dec; 24(12):1526-1535. PubMed ID: 31377937
[TBL] [Abstract][Full Text] [Related]
10. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
[TBL] [Abstract][Full Text] [Related]
11. Lower Levels of Adiponectin and Its Receptor Adipor1 in the Uveal Melanomas With Monosomy-3.
Tura A; Thieme C; Brosig A; Merz H; Ranjbar M; Vardanyan S; Zuo H; Maassen T; Kakkassery V; Grisanti S
Invest Ophthalmol Vis Sci; 2020 May; 61(5):12. PubMed ID: 32396633
[TBL] [Abstract][Full Text] [Related]
12. Investigating the Role of BAFF and Its Receptors in Renal Transplant Recipients with Chronic Antibody-Mediated Rejection.
Afzali S; Salehi S; Shahi A; Esmaeili M; Farashi Bonab S; Peykari A; Bagherpour F; Ansaripour B; Soleimanian T; Pour-Reza-Gholi F; Amirzargar A
J Immunol Res; 2021; 2021():6654992. PubMed ID: 33748289
[TBL] [Abstract][Full Text] [Related]
13. GDF-15: a novel serum marker for metastases in uveal melanoma patients.
Suesskind D; Schatz A; Schnichels S; Coupland SE; Lake SL; Wissinger B; Bartz-Schmidt KU; Henke-Fahle S
Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):887-95. PubMed ID: 21881845
[TBL] [Abstract][Full Text] [Related]
14. Additive Role of Immune System Infiltration and Angiogenesis in Uveal Melanoma Progression.
García-Mulero S; Alonso MH; Del Carpio LP; Sanz-Pamplona R; Piulats JM
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800878
[TBL] [Abstract][Full Text] [Related]
15. Loss of BAP1 expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development.
Figueiredo CR; Kalirai H; Sacco JJ; Azevedo RA; Duckworth A; Slupsky JR; Coulson JM; Coupland SE
J Pathol; 2020 Apr; 250(4):420-439. PubMed ID: 31960425
[TBL] [Abstract][Full Text] [Related]
16. Butyrophilin-Like 9 (BTNL9) Suppresses Invasion and Correlates with Favorable Prognosis of Uveal Melanoma.
Jiang Z; Liu F
Med Sci Monit; 2019 Apr; 25():3190-3198. PubMed ID: 31039142
[TBL] [Abstract][Full Text] [Related]
17. Analysis of monosomy-3 in immunomagnetically isolated circulating melanoma cells in uveal melanoma patients.
Tura A; Merz H; Reinsberg M; Lüke M; Jager MJ; Grisanti S; Lüke J
Pigment Cell Melanoma Res; 2016 Sep; 29(5):583-9. PubMed ID: 27390171
[TBL] [Abstract][Full Text] [Related]
18. M2/M1 ratio of tumor associated macrophages and PPAR-gamma expression in uveal melanomas with class 1 and class 2 molecular profiles.
Herwig MC; Bergstrom C; Wells JR; Höller T; Grossniklaus HE
Exp Eye Res; 2013 Feb; 107():52-8. PubMed ID: 23206928
[TBL] [Abstract][Full Text] [Related]
19. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
20. The immune cell landscape of metastatic uveal melanoma correlates with overall survival.
Tosi A; Cappellesso R; Dei Tos AP; Rossi V; Aliberti C; Pigozzo J; Fabozzi A; Sbaraglia M; Blandamura S; Del Bianco P; Chiarion-Sileni V; Rosato A
J Exp Clin Cancer Res; 2021 May; 40(1):154. PubMed ID: 33947438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]